Finance

Lists
Why is 543904 down 3,39%?
Dive Deeper
543904:BOM
Mankind Pharma Ltd
2 275,00 ₹
-3,39%
(-79,80) 1D
16 қаз., 15:50:40 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543904...
Open
2 354,60 ₹
High
2 355,00 ₹
Low
2 269,00 ₹
Mkt. cap
937,40 млрд
Avg. vol.
40,89 мың
Volume
32,86 мың
P/E ratio
46,03
52-wk high
2 640,30 ₹
52-wk low
1 909,90 ₹
EPS
49,42 ₹
No. of employees
20 мың
Open
2 354,60 ₹
High
2 355,00 ₹
Low
2 269,00 ₹
Mkt. cap
937,40 млрд
Avg. vol.
40,89 мың
Volume
32,86 мың
P/E ratio
46,03
52-wk high
2 640,30 ₹
52-wk low
1 909,90 ₹
EPS
49,42 ₹
No. of employees
20 мың
News stories
From web sources and news partners
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees20,5 мың
Founded1991
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
36,97 млрд
35,67 млрд
34,43 млрд
40,31 млрд
Cost of goods sold
10,62 млрд
9,78 млрд
11,71 млрд
10,98 млрд
Cost of revenue
10,62 млрд
9,78 млрд
11,71 млрд
10,98 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,25 млрд
8,24 млрд
15,80 млрд
9,14 млрд
Operating expense
19,35 млрд
18,92 млрд
14,77 млрд
21,02 млрд
Total operating expenses
29,98 млрд
28,70 млрд
26,48 млрд
32,00 млрд
Operating income
7,00 млрд
6,97 млрд
7,95 млрд
8,30 млрд
Other non operating income
918,70 млн
727,50 млн
-2,31 млрд
450,00 млн
EBT including unusual items
6,24 млрд
5,09 млрд
6,59 млрд
7,69 млрд
EBT excluding unusual items
6,24 млрд
6,16 млрд
5,59 млрд
7,69 млрд
Income tax expense
1,04 млрд
951,20 млн
997,50 млн
1,95 млрд
Effective tax rate
16,64%
18,69%
15,13%
25,39%
Other operating expenses
8,88 млрд
8,46 млрд
-3,26 млрд
9,63 млрд
Net income
5,12 млрд
4,09 млрд
5,54 млрд
5,68 млрд
Net profit margin
13,84%
11,46%
16,10%
14,09%
Earnings per share
12,38
11,99
13,89
13,74
Interest and investment income
-
-
580,50 млн
-
Interest expense
-1,70 млрд
-1,57 млрд
-1,36 млрд
-1,10 млрд
Net interest expenses
-1,70 млрд
-1,57 млрд
-778,20 млн
-1,10 млрд
Depreciation and amortization charges
2,22 млрд
2,23 млрд
2,23 млрд
2,26 млрд
EBITDA
9,20 млрд
8,42 млрд
9,97 млрд
10,33 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары